Heinrich-Heine-University Reports Findings in Myasthenia Gravis (Inter-alpha-try psin inhibitor heavy chain H3 is a potential biomarker for disease activity in m yasthenia gravis)

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Autoimmune Diseases an d Conditions - Myasthenia Gravis is the subject of a report. According to news r eporting out of Dusseldorf, Germany, by NewsRx editors, research stated, “Myasth enia gravis is a chronic antibody-mediated autoimmune disease disrupting neuromu scular synaptic transmission. Informative biomarkers remain an unmet need to str atify patients with active disease requiring intensified monitoring and therapy; their identification is the primary objective of this study.”

外文关键词：

DusseldorfGermanyEuropeAutoimmune Diseases and Conditions of the Nervous SystemBiomarkersCyborgsDiagnostics and ScreeningDrugs and TherapiesEmerging TechnologiesEnzyme InhibitorsEn zymes and CoenzymesHealth and MedicineMachine LearningMyastheniaMyasthen ia GravisNeurologyPeptide HydrolasesSerine EndopeptidasesSerine Proteina se InhibitorsTrypsinTrypsin Inhibitors

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Jul.2)